Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001415889-15-002006
Filing Date
2015-06-08
Accepted
2015-06-08 16:46:36
Documents
1
Effectiveness Date
2015-06-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10721
  Complete submission text file 0001415889-15-002006.txt   11978
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

EIN.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-241309 | Film No.: 15918858
SIC: 2835 In Vitro & In Vivo Diagnostic Substances